Xeme Biopharma
Chemicals & Related Products · Illinois, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1120 N Du Page Ave, Lombard, Illinois, 6...Phone Number
(844) 709-9363Website
www.xemebiopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Xeme Biopharma
XEME Biopharma Inc. is a clinical-stage company dedicated to developing innovative therapeutic cancer vaccines, focusing on active cancer immunotherapy. The company operates under FDA guidance and aims to advance cancer treatment beyond traditional methods such as surgery and chemotherapy. XEME utilizes two integrated technology platforms, Aggregon and Oncolipin, to manufacture personalized cancer vaccines, specifically targeting leukemia and lymphoma. Their lead products include Oncoquest-CLL and Oncoquest-L, designed for personalized treatment approaches.Explore more
Popular SearchesXEME Biopharma IncBiopharma IncXEME BiopharmaXeme Bio Pharma IncSIC Code 28,283NAICS Code 32,325Show more
Xeme Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xeme Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Xeme Biopharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Xeme Biopharma
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Xeme Biopharma launches new products
Click to see if Xeme Biopharma had a recent Job posting/layoffs
Earning: See what the market has to say on Xeme Biopharma recently announced quarterly report
Check if Xeme Biopharma has recently received funding, and reach out quickly before it becomes old news!
Xeme Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Xeme Biopharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Xeme Biopharma as Masked Content
Find 3 more new buyers
Compare Similar Companies to Xeme Biopharma
Compare insights from companies similar to Xeme Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Xeme Biopharma
<$5M
11-50
Private
-
2005
RR
Richard RobbFounder & Vice President, Research, Development & Quality Assurance
Company Profile Activity
Activity Insights
Xeme Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xeme Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xeme Biopharma.
Xeme Biopharma Tech Stack
A closer look at the technologies used by Xeme Biopharma
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xeme Biopharma
Sign Up For FreeTo access detailed company insights
XEME Biopharma Inc. is a clinical-stage company dedicated to developing innovative therapeutic cancer vaccines, focusing on active cancer immunotherapy. The company operates under FDA guidance and aims to advance cancer treatment beyond traditional methods such as surgery and chemotherapy. XEME utilizes two integrated technology platforms, Aggregon... Read More
